— Know what they know.
Not Investment Advice

ICUI NASDAQ

ICU Medical, Inc.
1W: +8.8% 1M: +12.3% 3M: +7.2% YTD: +2.5% 1Y: +6.7% 3Y: -23.0% 5Y: -30.6%
$142.81
+0.81 (+0.57%)
 
Weekly Expected Move ±5.0%
$123 $130 $137 $143 $150
NASDAQ · Healthcare · Medical - Instruments & Supplies · Alpha Radar Buy · Power 68 · $3.5B mcap · 25M float · 1.19% daily turnover · Short 62% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
38.7 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 12.2%  ·  5Y Avg: 1.3%
Cost Advantage ★
57
Intangibles
40
Switching Cost
27
Network Effect
23
Scale
47
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ICUI has No discernible competitive edge (38.7/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. ROIC of 12.2% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$165
Low
$165
Avg Target
$165
High
Based on 1 analyst since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 9Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$164.00
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-27 Needham Initiated $165 +22.2% $134.97
2026-04-27 KeyBanc $180 $164 -16 +31.4% $124.82
2026-04-17 Piper Sandler Jason Bednar $178 $163 -15 +29.3% $126.04
2026-02-20 Piper Sandler $153 $178 +25 +18.9% $149.74
2026-02-20 KeyBanc Brett Fishbin $173 $180 +7 +20.2% $149.74
2025-10-21 KeyBanc Brett Fishbin $198 $173 -25 +47.4% $117.34
2025-09-10 Piper Sandler Jason Bednar $145 $153 +8 +15.3% $132.74
2025-08-15 Piper Sandler Jason Bednar Initiated $145 +21.5% $119.32
2025-03-12 Raymond James Strong Buy $135 $97 -38 -30.2% $138.99
2024-10-15 KeyBanc Brett Fishbin Initiated $198 +9.8% $180.30
2024-10-13 Jefferies Michael Toomey Initiated $183 +2.4% $178.72
2024-06-16 Raymond James Jayson Bedford $190 $135 -55 +15.0% $117.44
2022-08-09 Raymond James $208 $190 -18 +1.0% $188.10
2022-08-08 Raymond James $235 $208 -27 +15.8% $179.63
2022-05-10 Raymond James Initiated $235 +16.8% $201.17

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Jun 10, 2026
DCF
4
ROE
3
ROA
4
D/E
1
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ICUI receives an overall rating of B. Strongest factors: DCF (4/5), ROA (4/5), P/B (4/5). Areas of concern: D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-11 B- B
2026-05-08 B B-
2026-05-07 B- B
2026-04-30 B B-
2026-04-24 B- B
2026-04-21 B B-
2026-03-20 B- B
2026-03-16 B B-
2026-03-06 B- B
2026-02-24 B B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

43 Grade B
Profitability
21
Balance Sheet
53
Earnings Quality
86
Growth
47
Value
40
Momentum
78
Safety
50
Cash Flow
36
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ICUI scores highest in Earnings Quality (86/100) and lowest in Profitability (21/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.07
Grey Zone
Piotroski F-Score
4/9
Beneish M-Score
-2.68
Unlikely Manipulator
Ohlson O-Score
-8.37
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BB+
Score: 47.9/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 3.61x
Accruals: -2.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ICUI scores 2.07, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ICUI scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ICUI's score of -2.68 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ICUI's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ICUI receives an estimated rating of BB+ (score: 47.9/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ICUI's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
76.06x
PEG
0.00x
P/S
1.65x
P/B
1.67x
P/FCF
40.45x
P/OCF
19.42x
EV/EBITDA
13.79x
EV/Revenue
2.01x
EV/EBIT
39.56x
EV/FCF
53.94x
Earnings Yield
1.42%
FCF Yield
2.47%
Shareholder Yield
0.27%
Graham Number
$59.09
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 76.1x earnings, ICUI is priced for high growth expectations. Graham's intrinsic value formula yields $59.09 per share, 140% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
4.881
NI / EBT
×
Interest Burden
0.087
EBT / EBIT
×
EBIT Margin
0.051
EBIT / Rev
×
Asset Turnover
0.523
Rev / Assets
×
Equity Multiplier
2.019
Assets / Equity
=
ROE
2.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ICUI's ROE of 2.3% is driven by Asset Turnover (0.523), indicating efficient use of assets to generate revenue. A tax burden ratio of 4.88 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$15.64
Price/Value
8.26x
Margin of Safety
-725.68%
Premium
725.68%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ICUI's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. ICUI trades at a 726% premium to its adjusted intrinsic value of $15.64, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 76.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$142.00
Median 1Y
$121.98
5th Pctile
$60.71
95th Pctile
$245.16
Ann. Volatility
41.3%
Analyst Target
$164.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Vivek Jain,
Chairman of the Board and Chief Executive Officer
$775,000 $4,500,023 $6,452,042
Christian Voigtlander, Operating
rating Officer
$500,000 $3,000,110 $3,950,110
Brian Bonnell, Financial
ancial Officer
$475,000 $3,000,110 $3,902,610
Virginia Sanzone, Corporate
Vice President, General Counsel
$430,000 $2,000,073 $2,817,073
Daniel Woolson, Corporate
Vice President, General Manager - Infusion Systems
$395,192 $1,350,135 $2,116,827

CEO Pay Ratio

134:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,452,042
Avg Employee Cost (SGA/emp): $48,093
Employees: 13,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
13,000
-13.3% YoY
Revenue / Employee
$171,540
Rev: $2,230,025,000
Profit / Employee
$56
NI: $732,000
SGA / Employee
$48,093
Avg labor cost proxy
R&D / Employee
$6,730
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 7.2% 7.6% 6.6% 2.7% 0.4% -2.5% -4.0% -2.5% -2.6% -1.5% -1.4% -2.8% -3.4% -5.3% -5.8% -4.6% -1.8% -0.4% 0.0% 2.3% 2.27%
ROA 6.0% 6.3% 5.7% 2.3% 0.3% -2.1% -2.3% -1.4% -1.5% -0.9% -0.7% -1.3% -1.6% -2.5% -2.7% -2.2% -0.9% -0.2% 0.0% 1.1% 1.12%
ROIC 8.7% 9.3% 9.4% 5.0% 1.4% -1.4% -0.9% 0.2% 0.3% 0.8% 0.5% 0.1% 0.2% -0.2% 1.0% 1.6% -4.9% -0.6% 0.4% 12.2% 12.21%
ROCE 7.6% 8.3% 7.4% 3.3% 1.2% -1.1% -1.1% 0.2% 0.3% 0.6% 0.4% -0.1% -0.0% -0.1% 1.1% 1.8% 3.1% 3.3% 2.6% 3.1% 3.09%
Gross Margin 38.4% 38.0% 37.4% 31.1% 29.9% 31.2% 30.3% 33.8% 35.0% 33.2% 29.2% 32.7% 34.8% 34.8% 36.1% 34.7% 37.9% 37.4% 37.4% 32.6% 32.64%
Operating Margin 10.7% 11.4% 7.0% -7.8% -0.0% -0.1% -0.0% 1.7% 0.5% 4.1% -2.1% -1.9% 1.3% 1.4% 6.0% 2.1% 1.9% 2.6% 4.7% 5.8% 5.78%
Net Margin 8.8% 9.2% 5.9% -7.0% -1.3% -2.2% -2.7% -1.7% -1.8% 1.3% -2.9% -7.0% -3.6% -5.6% -3.8% -2.6% 6.4% -0.6% -2.9% 5.7% 5.68%
EBITDA Margin 17.8% 18.0% 13.8% 2.2% 11.8% 9.8% 9.5% 11.7% 11.0% 51.6% 8.0% 8.0% 10.5% 11.0% 13.9% 10.6% 19.4% 12.4% 11.3% 15.2% 15.22%
FCF Margin 13.7% 13.5% 15.1% 9.0% 0.9% -3.0% -6.8% -4.4% -1.6% -0.2% 3.4% 3.4% 6.9% 7.3% 5.2% 5.6% 2.6% 2.9% 4.0% 3.7% 3.73%
OCF Margin 20.3% 20.3% 20.3% 13.9% 5.5% 1.1% -2.7% -0.8% 1.8% 3.3% 7.4% 7.6% 11.0% 10.9% 8.6% 8.7% 5.9% 6.9% 8.1% 7.8% 7.76%
ROE 3Y Avg snapshot only -1.79%
ROE 5Y Avg snapshot only -1.00%
ROA 3Y Avg snapshot only -0.81%
ROIC 3Y Avg snapshot only -5.72%
ROIC Economic snapshot only 11.27%
Cash ROA snapshot only 4.13%
Cash ROIC snapshot only 5.22%
CROIC snapshot only 2.51%
NOPAT Margin snapshot only 18.16%
Pretax Margin snapshot only 0.44%
R&D / Revenue snapshot only 3.96%
SGA / Revenue snapshot only 28.87%
SBC / Revenue snapshot only 2.03%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 43.26 46.38 50.18 127.36 718.97 -92.74 -50.85 -86.06 -88.47 -103.41 -81.19 -43.83 -40.92 -40.12 -32.29 -36.37 -88.37 -402.25 4811.60 70.18 76.058
P/S Ratio 3.49 3.91 3.93 3.42 2.21 1.76 1.66 1.72 1.87 1.29 1.07 1.15 1.26 1.90 1.60 1.41 1.38 1.28 1.58 1.51 1.649
P/B Ratio 2.97 3.38 3.20 3.26 2.43 2.23 1.81 1.90 2.05 1.39 1.13 1.22 1.36 2.10 1.93 1.73 1.66 1.51 1.66 1.53 1.669
P/FCF 25.55 28.97 26.01 37.98 245.88 -59.52 -24.44 -38.62 -117.49 -534.86 31.20 33.73 18.18 26.16 30.51 25.37 53.48 44.11 39.36 40.45 40.453
P/OCF 17.17 19.25 19.35 24.50 39.79 162.16 106.27 39.61 14.49 15.22 11.40 17.46 18.63 16.26 23.52 18.57 19.58 19.42 19.425
EV/EBITDA 20.09 21.31 21.77 26.90 18.40 16.80 27.66 22.27 24.15 9.45 8.39 9.24 9.87 26.86 19.75 17.02 14.25 13.25 15.48 13.79 13.790
EV/Revenue 3.21 3.64 3.54 3.08 1.91 1.51 2.32 2.38 2.53 1.97 1.71 1.79 1.89 2.52 2.16 1.96 1.94 1.85 2.06 2.01 2.011
EV/EBIT 34.43 36.08 37.51 85.24 169.82 -169.22 -121.52 650.37 485.04 185.16 247.01 -721.17 -2958.34 -1532.25 126.67 72.67 40.03 35.42 49.37 39.56 39.558
EV/FCF 23.50 26.92 23.38 34.21 213.20 -50.89 -34.28 -53.45 -159.16 -815.44 49.97 52.54 27.28 34.67 41.22 35.29 75.31 63.97 51.47 53.94 53.939
Earnings Yield 2.3% 2.2% 2.0% 0.8% 0.1% -1.1% -2.0% -1.2% -1.1% -1.0% -1.2% -2.3% -2.4% -2.5% -3.1% -2.7% -1.1% -0.2% 0.0% 1.4% 1.42%
FCF Yield 3.9% 3.5% 3.8% 2.6% 0.4% -1.7% -4.1% -2.6% -0.9% -0.2% 3.2% 3.0% 5.5% 3.8% 3.3% 3.9% 1.9% 2.3% 2.5% 2.5% 2.47%
PEG Ratio snapshot only 0.001
EV/OCF snapshot only 25.901
EV/Gross Profit snapshot only 5.530
Acquirers Multiple snapshot only 54.061
Shareholder Yield snapshot only 0.27%
Graham Number snapshot only $59.09
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 4.68 4.68 5.13 5.13 5.13 5.13 2.50 2.50 2.50 2.50 2.53 2.53 2.53 2.53 2.59 2.59 2.59 2.59 2.36 2.36 2.360
Quick Ratio 3.07 3.07 3.68 3.68 3.68 3.68 1.09 1.09 1.09 1.09 1.06 1.06 1.06 1.06 1.54 1.54 1.54 1.54 1.13 1.13 1.126
Debt/Equity 0.04 0.04 0.03 0.03 0.03 0.03 0.83 0.83 0.83 0.83 0.80 0.80 0.80 0.80 0.84 0.84 0.84 0.84 0.66 0.66 0.656
Net Debt/Equity -0.24 -0.24 -0.32 -0.32 -0.32 -0.32 0.73 0.73 0.73 0.73 0.68 0.68 0.68 0.68 0.68 0.68 0.68 0.68 0.51 0.51 0.511
Debt/Assets 0.03 0.03 0.02 0.02 0.02 0.02 0.38 0.38 0.38 0.38 0.39 0.39 0.39 0.39 0.39 0.39 0.39 0.39 0.34 0.34 0.344
Debt/EBITDA 0.26 0.24 0.21 0.26 0.24 0.25 9.05 7.05 7.21 3.71 3.71 3.89 3.87 7.75 6.31 5.89 5.09 5.06 4.68 4.43 4.427
Net Debt/EBITDA -1.75 -1.62 -2.44 -2.96 -2.82 -2.85 7.94 6.18 6.32 3.25 3.15 3.31 3.29 6.59 5.13 4.78 4.13 4.11 3.64 3.45 3.448
Interest Coverage 126.92 265.49 144.57 3.88 0.66 -0.35 -0.61 0.10 0.13 0.25 0.15 -0.05 -0.01 -0.04 0.38 0.60 1.09 1.24 0.96 2.14 2.140
Equity Multiplier 1.17 1.17 1.16 1.16 1.16 1.16 2.16 2.16 2.16 2.16 2.06 2.06 2.06 2.06 2.14 2.14 2.14 2.14 1.91 1.91 1.907
Cash Ratio snapshot only 0.617
Debt Service Coverage snapshot only 6.140
Cash to Debt snapshot only 0.221
FCF to Debt snapshot only 0.058
Defensive Interval snapshot only 253.3 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.74 0.75 0.72 0.85 0.98 1.12 0.71 0.72 0.72 0.70 0.51 0.51 0.52 0.53 0.56 0.56 0.55 0.54 0.54 0.52 0.523
Inventory Turnover 2.48 2.49 2.73 3.28 3.93 4.60 3.21 3.21 3.14 3.05 2.16 2.17 2.21 2.24 2.41 2.43 2.35 2.28 2.35 2.29 2.286
Receivables Turnover 7.84 7.94 11.45 13.40 15.49 17.76 13.92 14.07 14.00 13.73 11.79 11.78 12.02 12.21 13.83 14.05 13.78 13.48 12.28 11.87 11.871
Payables Turnover 8.07 8.10 10.78 12.99 15.54 18.20 10.65 10.67 10.42 10.14 8.30 8.33 8.50 8.59 10.45 10.54 10.21 9.89 9.32 9.08 9.077
DSO 47 46 32 27 24 21 26 26 26 27 31 31 30 30 26 26 26 27 30 31 30.7 days
DIO 147 147 134 111 93 79 114 114 116 120 169 168 165 163 152 150 155 160 155 160 159.6 days
DPO 45 45 34 28 23 20 34 34 35 36 44 44 43 43 35 35 36 37 39 40 40.2 days
Cash Conversion Cycle 149 148 132 110 93 80 106 105 107 110 156 155 152 151 143 142 146 150 146 150 150.2 days
Fixed Asset Turnover snapshot only 4.260
Operating Cycle snapshot only 190.4 days
Cash Velocity snapshot only 7.003
Capital Intensity snapshot only 1.878
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 1.9% 2.4% 3.6% 22.3% 39.3% 57.6% 73.2% 49.6% 28.8% 10.1% -0.9% -2.1% 0.5% 4.0% 5.4% 7.2% 3.0% -0.8% -6.3% -10.9% -10.89%
Net Income 24.5% 34.4% 18.7% -55.9% -94.7% -1.4% -1.7% -2.1% -9.9% 27.8% 60.1% -28.9% -46.0% -3.0% -3.0% -58.0% 47.8% 93.4% 1.0% 1.5% 1.49%
EPS 23.4% 33.3% 17.7% -59.6% -95.2% -1.3% -1.7% -2.1% -9.8% 29.1% 60.3% -27.8% -44.1% -2.9% -2.9% -55.9% 48.5% 93.4% 1.0% 1.5% 1.48%
FCF 1.5% 70.9% 57.0% -7.6% -90.9% -1.3% -1.8% -1.7% -3.3% 91.0% 1.5% 1.8% 5.4% 32.4% 61.4% 74.3% -61.7% -60.6% -28.1% -40.2% -40.15%
EBITDA 9.7% 25.6% 14.2% -8.6% -9.5% -17.1% -10.4% 39.6% 30.0% 1.6% 1.4% 78.1% 83.0% -53.0% -43.4% -36.4% -26.7% 47.5% 14.5% 12.9% 12.87%
Op. Income 17.9% 42.1% 25.6% -44.8% -82.4% -1.1% -1.3% -84.1% -42.7% 2.8% 1.5% -67.9% -32.8% -1.2% 88.2% 23.0% 8.0% 11.8% 45.3% 20.6% 20.61%
OCF Growth snapshot only -20.11%
Asset Growth snapshot only -3.65%
Equity Growth snapshot only 8.07%
Debt Growth snapshot only -15.19%
Shares Change snapshot only 2.62%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -4.0% -3.2% -2.0% 4.3% 10.8% 16.5% 21.7% 22.2% 22.3% 21.1% 21.1% 21.4% 21.7% 21.8% 21.9% 16.2% 10.0% 4.3% -0.7% -2.2% -2.20%
Revenue 5Y 28.6% 28.2% 28.3% 23.5% 18.2% 14.9% 12.0% 10.2% 9.7% 9.5% 10.0% 10.7% 11.9% 12.6% 13.5% 13.9% 13.6% 12.9% 11.9% 11.3% 11.34%
EPS 3Y 6.2% 8.2% 49.9% -11.8% -52.8%
EPS 5Y 7.4% 8.1% 5.7% -19.5% -37.4% -62.5% -15.7% -15.70%
Net Income 3Y 6.4% 8.4% 53.0% -9.0% -51.1%
Net Income 5Y 12.8% 13.1% 10.3% -16.3% -35.0% -61.5% -13.1% -13.15%
EBITDA 3Y -13.4% -13.3% -0.2% -6.3% -1.0% 0.4% -4.0% 8.7% 8.9% 38.5% 34.9% 31.5% 29.1% -0.2% 6.7% 16.5% 20.3% 20.9% 15.8% 8.5% 8.51%
EBITDA 5Y 13.1% 14.1% 12.6% 9.2% 23.7% 20.1% 1.8% 2.2% -5.3% 6.6% 16.4% 15.4% 18.2% 4.0% 3.7% 7.8% 11.6% 13.0% 9.7% 10.3% 10.28%
Gross Profit 3Y -5.1% -5.5% -4.8% -0.5% 5.2% 9.7% 13.9% 16.3% 17.4% 17.7% 17.0% 17.4% 16.8% 16.7% 18.8% 15.8% 12.8% 9.2% 5.6% 2.8% 2.84%
Gross Profit 5Y 19.4% 19.5% 19.5% 17.8% 16.2% 13.9% 10.4% 8.2% 6.3% 5.3% 5.4% 5.7% 8.0% 9.3% 11.8% 13.2% 13.1% 13.2% 12.2% 11.6% 11.61%
Op. Income 3Y 17.1% 18.9% 78.7% 3.6% -23.9% -56.2% -50.8% -26.9% -38.5% -69.6% -59.2% -29.6% 6.9% 51.4% 1.1% 1.10%
Op. Income 5Y 6.2% 9.1% 8.2% 5.3% 12.3% -30.5% -14.3% 1.1% -43.7% -29.8% -16.7% -8.4% -6.3% -3.4% -8.7% -4.1% -4.06%
FCF 3Y 7.6% 24.8% 49.6% 34.5% 1.3% -15.2% -19.9% -3.0% -0.9% -14.5% -1.0% 56.3%
FCF 5Y 27.1% 24.0% 24.9% 5.4% 6.2% 1.6% 1.3% 17.6% -2.9% -8.1% -6.7% -11.7% -11.73%
OCF 3Y 2.4% 10.6% 18.6% 10.3% -1.6% -40.0% -37.9% -27.6% -9.3% -10.0% -0.8% -1.1% -8.6% -0.8% 12.0% 92.9%
OCF 5Y 29.7% 26.6% 24.4% 38.6% -24.6% -30.1% -17.8% 0.7% 1.3% 19.7% 19.9% 14.9% 5.2% -3.8% -3.8% -4.2% -6.5% -6.52%
Assets 3Y 5.6% 5.6% 5.9% 5.9% 5.9% 5.9% 38.7% 38.7% 38.7% 38.7% 35.4% 35.4% 35.4% 35.4% 30.8% 30.8% 30.8% 30.8% -3.6% -3.6% -3.56%
Assets 5Y 23.0% 23.0% 21.7% 21.7% 21.7% 21.7% 24.7% 24.7% 24.7% 24.7% 22.5% 22.5% 22.5% 22.5% 20.0% 20.0% 20.0% 20.0% 18.1% 18.1% 18.09%
Equity 3Y 7.8% 7.8% 8.5% 8.5% 8.5% 8.5% 14.9% 14.9% 14.9% 14.9% 12.2% 12.2% 12.2% 12.2% 6.7% 6.7% 6.7% 6.7% 0.5% 0.5% 0.54%
Book Value 3Y 7.6% 7.7% 6.3% 5.2% 4.8% 4.7% 10.6% 10.8% 10.7% 10.3% 8.2% 8.2% 7.9% 7.9% 2.7% 5.4% 5.6% 5.6% -0.4% -1.0% -1.04%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.52 0.55 0.59 0.76 0.82 0.66 0.42 0.43 0.51 0.57 0.58 0.70 0.81 0.83 0.79 0.87 0.90 0.84 0.65 0.57 0.574
Earnings Stability 0.47 0.60 0.39 0.00 0.03 0.07 0.16 0.13 0.51 0.54 0.33 0.68 0.67 0.75 0.78 0.93 0.76 0.51 0.41 0.23 0.227
Margin Stability 0.82 0.83 0.83 0.89 0.94 0.92 0.91 0.94 0.93 0.91 0.89 0.89 0.92 0.92 0.92 0.94 0.94 0.94 0.92 0.93 0.935
Rev. Growth Consistency 0.50 0.50 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.50 1.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 1.00 1.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
FCF Positive Streak 1 1 1 1 1 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1
Earnings Persistence 0.90 0.86 0.93 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.81 0.50 0.20 0.20 0.200
Earnings Smoothness 0.78 0.71 0.83 0.22 0.00
ROE Trend 0.02 0.01 -0.00 -0.04 -0.06 -0.09 -0.10 -0.07 -0.06 -0.04 -0.03 -0.03 -0.02 -0.03 -0.04 -0.02 0.01 0.03 0.04 0.06 0.060
Gross Margin Trend -0.01 0.00 0.01 -0.01 -0.03 -0.05 -0.06 -0.04 -0.02 -0.02 -0.01 -0.01 -0.00 0.00 0.03 0.03 0.03 0.04 0.03 0.03 0.026
FCF Margin Trend 0.11 0.09 0.10 0.01 -0.09 -0.14 -0.19 -0.15 -0.09 -0.06 -0.01 0.01 0.07 0.09 0.07 0.06 -0.00 -0.01 -0.00 -0.01 -0.008
Sustainable Growth Rate 7.2% 7.6% 6.6% 2.7% 0.4% 0.0% 2.3% 2.27%
Internal Growth Rate 6.4% 6.8% 6.0% 2.3% 0.3% 0.0% 1.1% 1.14%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 2.52 2.41 2.59 5.20 18.07 -0.57 0.84 0.42 -0.83 -2.61 -5.60 -2.88 -3.59 -2.30 -1.73 -2.24 -3.76 -21.66 245.69 3.61 3.613
FCF/OCF 0.67 0.66 0.74 0.65 0.16 -2.72 2.49 5.25 -0.90 -0.07 0.46 0.45 0.63 0.67 0.61 0.64 0.44 0.42 0.50 0.48 0.480
FCF/Net Income snapshot only 1.735
OCF/EBITDA snapshot only 0.532
CapEx/Revenue 6.7% 6.8% 5.2% 4.9% 4.6% 4.0% 4.1% 3.6% 3.4% 3.5% 3.9% 4.2% 4.1% 3.6% 3.3% 3.1% 3.3% 4.0% 4.1% 4.0% 4.04%
CapEx/Depreciation snapshot only 0.425
Accruals Ratio -0.09 -0.09 -0.09 -0.10 -0.05 -0.03 -0.00 -0.01 -0.03 -0.03 -0.04 -0.05 -0.07 -0.08 -0.07 -0.07 -0.04 -0.04 -0.04 -0.03 -0.029
Sloan Accruals snapshot only -0.100
Cash Flow Adequacy snapshot only 1.924
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.5% 0.4% 0.4% 0.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.48 $0.47 $0.47 $0.47 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 14.9% 14.9% 7.2% 6.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 8.1% 20.2% 1.5% 12.0% 19.0% 18.98%
Div. Increase Streak 0 0 0 0
Chowder Number
Buyback Yield 0.0% 0.0% 0.2% 0.2% 0.2% 0.2% 0.3% 0.5% 0.5% 0.7% 0.8% 0.4% 0.3% 0.2% 0.3% 0.4% 0.4% 0.4% 0.2% 0.3% 0.27%
Net Buyback Yield -0.2% -0.1% -0.0% 0.0% 0.0% 0.1% 0.2% 0.5% 0.4% 0.6% 0.7% 0.3% 0.2% 0.1% 0.0% 0.0% -0.1% 0.0% 0.1% 0.1% 0.09%
Total Shareholder Return -0.2% -0.1% -0.0% 0.0% 0.0% 0.1% 0.2% 0.5% 0.4% 0.6% 1.2% 0.7% 0.6% 0.3% 0.0% 0.0% -0.1% 0.0% 0.1% 0.1% 0.09%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.87 0.84 0.84 1.00 -0.53 0.56 0.65 0.63 0.61 0.44 0.38 0.58 0.72 1.00 1.78 2.33 -2.32 -0.25 0.23 4.88 4.881
Interest Burden (EBT/EBIT) 0.99 0.99 0.99 0.74 -0.52 3.83 2.62 -8.66 -6.59 -2.64 -5.01 18.11 66.95 28.79 -1.63 -0.62 0.14 0.25 0.03 0.09 0.087
EBIT Margin 0.09 0.10 0.09 0.04 0.01 -0.01 -0.02 0.00 0.01 0.01 0.01 -0.00 -0.00 -0.00 0.02 0.03 0.05 0.05 0.04 0.05 0.051
Asset Turnover 0.74 0.75 0.72 0.85 0.98 1.12 0.71 0.72 0.72 0.70 0.51 0.51 0.52 0.53 0.56 0.56 0.55 0.54 0.54 0.52 0.523
Equity Multiplier 1.20 1.20 1.17 1.17 1.17 1.17 1.73 1.73 1.73 1.73 2.11 2.11 2.11 2.11 2.10 2.10 2.10 2.10 2.02 2.02 2.019
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $4.76 $5.03 $4.73 $1.75 $0.23 $-1.62 $-3.10 $-1.92 $-2.01 $-1.15 $-1.23 $-2.45 $-2.90 $-4.54 $-4.81 $-3.82 $-1.50 $-0.30 $0.03 $1.84 $1.84
Book Value/Share $69.22 $69.13 $74.11 $68.34 $67.62 $67.59 $87.12 $87.03 $86.81 $85.77 $87.96 $87.66 $87.05 $86.89 $80.24 $80.09 $79.54 $79.61 $86.03 $84.34 $85.28
Tangible Book/Share $58.61 $58.54 $63.48 $58.54 $57.93 $57.90 $-14.26 $-14.25 $-14.21 $-14.04 $-9.10 $-9.07 $-9.00 $-8.99 $-8.51 $-8.49 $-8.43 $-8.44 $-0.38 $-0.38 $-0.38
Revenue/Share $58.92 $59.65 $60.36 $65.19 $74.52 $85.43 $95.05 $96.01 $95.28 $92.30 $93.58 $93.19 $94.46 $95.76 $97.26 $98.62 $96.02 $94.00 $90.37 $85.64 $87.08
FCF/Share $8.06 $8.06 $9.13 $5.86 $0.67 $-2.53 $-6.44 $-4.27 $-1.52 $-0.22 $3.20 $3.18 $6.53 $6.97 $5.09 $5.47 $2.47 $2.72 $3.63 $3.19 $3.25
OCF/Share $11.98 $12.12 $12.27 $9.09 $4.13 $0.93 $-2.59 $-0.81 $1.68 $3.00 $6.88 $7.05 $10.42 $10.44 $8.33 $8.54 $5.62 $6.46 $7.29 $6.65 $6.76
Cash/Share $18.93 $18.90 $26.01 $23.99 $23.74 $23.73 $8.88 $8.87 $8.85 $8.74 $10.55 $10.52 $10.44 $10.42 $12.60 $12.57 $12.49 $12.50 $12.47 $12.23 $11.64
EBITDA/Share $9.42 $10.18 $9.80 $7.46 $7.75 $7.67 $7.99 $10.25 $10.00 $19.19 $19.04 $18.10 $18.05 $8.99 $10.62 $11.35 $13.06 $13.13 $12.05 $12.49 $12.49
Debt/Share $2.43 $2.43 $2.07 $1.91 $1.89 $1.88 $72.30 $72.22 $72.04 $71.17 $70.58 $70.34 $69.85 $69.72 $67.03 $66.90 $66.44 $66.50 $56.39 $55.29 $55.29
Net Debt/Share $-16.50 $-16.48 $-23.95 $-22.08 $-21.85 $-21.84 $63.42 $63.35 $63.19 $62.43 $60.03 $59.83 $59.41 $59.30 $54.43 $54.33 $53.95 $54.00 $43.92 $43.06 $43.06
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 2.074
Altman Z-Prime snapshot only 3.609
Piotroski F-Score 7 8 8 6 6 5 3 3 4 5 5 3 4 5 5 5 6 6 5 4 4
Beneish M-Score -3.25 -3.22 -2.92 -2.64 -2.34 -2.26 -0.54 -0.62 -0.67 -0.59 -2.93 -2.97 -3.05 -3.14 -2.87 -2.77 -2.64 -2.62 -2.80 -2.68 -2.680
Ohlson O-Score snapshot only -8.370
Net-Net WC snapshot only $-29.75
EVA snapshot only $70760850.83
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB+
Credit Score 93.77 93.57 93.28 79.52 70.94 64.29 32.62 35.63 36.25 33.43 35.28 33.77 34.11 36.71 39.39 41.46 42.18 42.26 40.02 47.87 47.871
Credit Grade snapshot only 11
Credit Trend snapshot only 6.412
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 32
Sector Credit Rank snapshot only 45

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms